Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors.

Saved in:
Bibliographic Details
Title: Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors.
Authors: Carrera-Bastos P; Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, Spain. pmcbastos@gmail.com.; Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Malmö, Sweden. pmcbastos@gmail.com.; Rio Maior School of Sport - Santarém Polytechnic University, Rio Maior, Portugal. pmcbastos@gmail.com., Muskiet MHA; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands., Mata-Ordoñez F; Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain.; Department of Cell Biology, Physiology, and Immunology, University of Cordoba, Cordoba, Spain.; Reina Sofia University Hospital (HURS), Cordoba, Spain., Pruimboom L; Pontifical University of Salamanca, Salamanca, Spain.; PNI Europe, The Hague, The Netherlands., Lucia A; Faculty of Medicine, Health Sciences, and Sports. Department of Sport Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, Spain.; Research Institute of the Hospital 12 de Octubre, Madrid, Spain., Luque RM; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain.; Department of Cell Biology, Physiology, and Immunology, University of Cordoba, Cordoba, Spain.; Reina Sofia University Hospital (HURS), Cordoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Cordoba, Spain., Muskiet FAJ; Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. f.a.j.muskiet@gmail.com.
Source: Reviews in endocrine & metabolic disorders [Rev Endocr Metab Disord] 2026 Feb; Vol. 27 (1), pp. 69-90. Date of Electronic Publication: 2025 Oct 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 100940588 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2606 (Electronic) Linking ISSN: 13899155 NLM ISO Abbreviation: Rev Endocr Metab Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-2606
DOI:10.1007/s11154-025-09996-z